|
CDRF is one of the centers for a Phase II, randomized, double–blind, placebo controlled, chemoprevention study to “Determine the Clinical Efficacy and Safety of Curcumin in Oral Premalignant Lesions”. This project is funded by the Department of Biotechnology, Ministry of Science & Technology, Government of India.
A Phase III, Open-Label, Randomized, Assessment-Blinded Clinical Trial to Compare the Safety and Efficacy of Topical Gentian Violet (GV) to that of Nystatin Oral Suspension for the Treatment of Oropharyngeal Candidiasis in HIV-1 Infected Participants in Non-U.S. Settings.
The Efficacy of CPP-ACP in the prevention of white spot lesions following fixed orthodontic therapy- A Randomized Controlled trial was submitted to Indian Council of Medical Research.
CDRF is one of the 9 international centres recognized for a randomized clinical trial comparing Zygomatic Implants Vs Conventional implants in augumented maxilla, a study co-ordinated by Marco Esposito, Head of Cochrane Oral Health Group.
A fuzzy mathematical model using an expanded risk factor assessment will improve early detection and monitoring of type-2 diabetes mellitus was submitted to Department of Biotechnology.
|
|
|
